3 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 6 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
Follow Fresenius Kabi: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The FORCE Trial Pilot: Fish Oil-enriched Nutrition for Radiotherapy in Cancer of the hEad and Neck Nutrition counseling, Fresubin Supportan - Head &Amp;Amp; Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Anna Arthur, PhD | 15 | 2027-06-01 | 2026-08-07 |
| Intravenous Fish Oil Emulsion in Critically Ill Patients With High Inflammatory Status. Omegaven (10% fish-oil emulsion; Fresenius-Kabi) - Critical Illness | Phase 2 | Recruiting | Lee Zheng Yii | 159 | 2026-07-07 | 2026-10-20 |
| umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN) cord blood-RBC concentrates, adult donor RBC concentrates - Retinopathy of Prematurity | Phase 2 | Completed | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 146 | 2021-12-01 | 2025-02-27 |
| Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients Ketosteril® - Renal Insufficiency, Chronic | Phase 1 / Phase 2 | Completed | Fresenius Kabi | 23 | 2017-03-30 | 2018-05-14 |
| Pilot Study Efficacy and Tolerance Fish Oil Emulsion Daunorubicin and Cytarabine Treatment of AML Younger Patients OMEGAVEN, Daunorubicin, Cytarabine - Acute Myeloid Leukemia (AML) | Phase 2 | Completed | French Innovative Leukemia Organisation | 30 | 2013-11-01 | 2018-04-27 |
| Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants? Intralipid 20%, SMOFlipid 20% - Short Bowel Syndrome, Intestinal Failure | Phase 2 | Unknown | The Hospital for Sick Children | 24 | 2009-01-01 | 2011-11-03 |
Critical Illness (1) · Head and Neck Neoplasms (1) · Hyperphagia (1) · Intestinal Failure (1) · Leukemia, Myeloid, Acute (1) · Liver Failure (1) · Neoplasms (1) · Renal Insufficiency, Chronic (1) · Retinopathy of Prematurity (1) · Sarcopenia (1) · Short Bowel Syndrome (1)
fish oil triglycerides (2) · Cytarabine (1) · Daunorubicin (1) · ketosteril (1)
Canada (1) · Czechia (1) · France (1) · Italy (1) · Malaysia (1)
John F Stover, M.D. (1) · Luciana Teofili, MD (1) · Paul Wales (1) · Shahnaz Hasan (1) · Zheng Yii Lee, PhD (1)
PMID 26838529, PMID 29505137, PMID 29556926, PMID 30142422, PMID 34579024, PMID 35170737, PMID 35565223, PMID 35697729, PMID 36514106, PMID 39113069, PMID 40449504
2016 (1)